IPSC
Price:
$1.46
Market Cap:
$123.69M
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106,...[Read more]
Industry
Biotechnology
IPO Date
2021-06-18
Stock Exchange
NASDAQ
Ticker
IPSC
According to Century Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 138.60M. This represents a change of -28.32% compared to the average of 193.37M of the last 4 quarters.
The mean historical Enterprise Value of Century Therapeutics, Inc. over the last ten years is 750.44M. The current 138.60M Enterprise Value has changed 1.75% with respect to the historical average. Over the past ten years (40 quarters), IPSC's Enterprise Value was at its highest in in the June 2021 quarter at 1.35B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.
Average
750.44M
Median
839.40M
Minimum
197.77M
Maximum
1.25B
Discovering the peaks and valleys of Century Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.18%
Maximum Annual Enterprise Value = 1.25B
Minimum Annual Increase = -68.85%
Minimum Annual Enterprise Value = 197.77M
Year | Enterprise Value | Change |
---|---|---|
2023 | 197.77M | -24.35% |
2022 | 261.44M | -68.85% |
2021 | 839.40M | -32.63% |
2020 | 1.25B | 3.18% |
The current Enterprise Value of Century Therapeutics, Inc. (IPSC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
432.87M
5-year avg
750.44M
10-year avg
750.44M
Century Therapeutics, Inc.’s Enterprise Value is less than Edgewise Therapeutics, Inc. (1.60B), less than C4 Therapeutics, Inc. (369.73M), less than Mineralys Therapeutics, Inc. (490.57M), less than Cullinan Oncology, Inc. (930.13M), greater than Passage Bio, Inc. (44.87M), greater than Homology Medicines, Inc. (-103303255.00), less than Generation Bio Co. (210.95M), less than Stoke Therapeutics, Inc. (586.20M), less than Erasca, Inc. (689.13M), greater than NGM Biopharmaceuticals, Inc. (69.72M), less than Keros Therapeutics, Inc. (1.58B), less than Monte Rosa Therapeutics, Inc. (284.72M), greater than Kezar Life Sciences, Inc. (30.16M), less than Nkarta, Inc. (340.55M), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than aTyr Pharma, Inc. (138.44M), less than Relay Therapeutics, Inc. (752.45M), less than Blueprint Medicines Corporation (6.16B),
Company | Enterprise Value | Market cap |
---|---|---|
1.60B | $1.64B | |
369.73M | $374.42M | |
490.57M | $558.43M | |
930.13M | $1.04B | |
44.87M | $43.48M | |
-103303255.00 | $3.02M | |
210.95M | $145.50M | |
586.20M | $773.92M | |
689.13M | $807.96M | |
69.72M | $128.53M | |
1.58B | $1.97B | |
284.72M | $349.21M | |
30.16M | $40.82M | |
340.55M | $375.37M | |
138.26M | $181.50M | |
138.44M | $131.12M | |
752.45M | $835.47M | |
6.16B | $5.47B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Century Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Century Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Century Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Century Therapeutics, Inc. (IPSC)?
What is the 3-year average Enterprise Value for Century Therapeutics, Inc. (IPSC)?
What is the 5-year average Enterprise Value for Century Therapeutics, Inc. (IPSC)?
How does the current Enterprise Value for Century Therapeutics, Inc. (IPSC) compare to its historical average?